Aclarion, Inc. (ACON)
2.43
-0.09
(-3.57%)
USD |
NASDAQ |
Aug 28, 11:24
Aclarion EPS Diluted (Quarterly) : -1.116 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.116 |
| March 31, 2026 | -1.340 |
| December 31, 2025 | -2.211 |
| September 30, 2025 | -2.930 |
| June 30, 2025 | -2.749 |
| March 31, 2025 | -9.318 |
| December 31, 2024 | -1587.94 |
| September 30, 2024 | -0.146 |
| June 30, 2024 | -0.1507 |
| March 31, 2024 | -0.4408 |
| December 31, 2023 | -1.533 |
| September 30, 2023 | -1.873 |
| Date | Value |
|---|---|
| June 30, 2023 | -2.828 |
| March 31, 2023 | -2.385 |
| December 31, 2022 | -1.612 |
| September 30, 2022 | -3.341 |
| June 30, 2022 | -68147.20 |
| March 31, 2022 | -2.503 |
| December 31, 2021 | -7.632 |
| September 30, 2021 | -518225.0 |
| June 30, 2021 | -108460.4 |
| March 31, 2021 | -1.495 |
| December 31, 2020 | -1.605 |
| September 30, 2020 | -5.763 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biotricity, Inc. | -0.0463 |
| MedLink International, Inc. | -- |
| Agilent Technologies, Inc. | 1.279 |
| Abbott Laboratories | 0.5324 |
| Align Technology, Inc. | 1.514 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.748M |
| Revenue (Quarterly) | 0.0252M |
| Total Expenses (Quarterly) | 2.773M |
| Enterprise Value | -10.11M |
| Gross Profit Margin (Quarterly) | -212.7% |
| Profit Margin (Quarterly) | -10.90K% |
| Earnings Yield | -312.6% |
| Normalized Earnings Yield | -312.62 |